ARCHIVES

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 03 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

DCE Board Approves Epidemiology Contract Recompetitions

March 17, 1995

NIH Emerges From Republican Revolution With Another Increase in Appropriations

October 4, 1996

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988